Hermes Medical Solutions releases a new version of Hermia Voxel Dosimetry

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, launches the latest version of Hermia Voxel Dosimetry.

“The new release of the Hermia Voxel Dosimetry is a big step forward in personalized dosimetry for Theranostics. It includes additional isotopes, automated workflows and uses the advanced Hermia Monte Carlo dose calculations. It will enable faster and more precise dosimetry planning for oncology treatments.” Tom Francke, CEO of Hermes Medical Solutions.

Hermia Voxel Dosimetry introduces several new features intended to improve its dosimetry aspect and simplify workflows. It is furthermore optimized to calculate dose maps faster than prior versions.

Discover below some of the highlights of the latest version of Hermia Voxel Dosimetry, which has just been released* 

Time saving features

•    Automatic organ segmentation 
•    Improved ability to fill in information automatically from header
•    Reduced calculation times
•    Automated workflow configuration options

Enhancements

•    Enhanced alignment of voxel-to-voxel registration with new deformable registration to accommodate patient movement and breathing corrections
•    Reduced sensitivity to noise
•    New alpha emitting isotopes
•    Improved compatibility with Spectrum Dynamics Quantitative SPECT

Discover the many highlights from the Hermia Software Suite for Nuclear Medicine and Molecular Imaging at the upcoming EANM conference. 

*Currently, in European countries accepting English labelling and in Hong Kong. Further market releases will follow. May be subject to regulatory clearance in your market. Not for sale in the US.

About Hermes Medical Solutions

Hermes Medical Solutions continuously innovates to enable faster and more personalized diagnosis and therapies in molecular imaging. With Hermia, we empower healthcare professionals with state-of-the-art software for all clinical scenarios into ONE vendor-neutral platform. Powerful tools enable clinicians to simplify their workflow and keep pace with the fast development of scanners, tracers and procedures in nuclear medicine. The result is improved quality in patient management and decision support for thousands of healthcare providers and their patients worldwide.
www.hermesmedical.com

Contact

Tom Francke
CEO, Assoc. Prof.

Hermes Medical Solutions AB (HQ)
Strandbergsgatan 16
112 51 Stockholm, Sweden
Tel: +46 70 166 1234
tom.francke@hermesmedical.com